Literature DB >> 16704639

The dermal stem cell factor and c-kit are overexpressed in melasma.

H Y Kang1, J S Hwang, J Y Lee, J H Ahn, J-Y Kim, E-S Lee, W H Kang.   

Abstract

BACKGROUND: The pathogenesis of melasma has not yet been clearly demonstrated. We tried to determine whether the stem cell factor (SCF) and its receptor c-kit are involved in the mechanism of hyperpigmentation of melasma because this factor is highly implicated in the stimulation of melanocyte function in vitro and in vivo.
OBJECTIVES: The present study was conducted to investigate the expression of SCF and c-kit on the lesions of melasma compared with nonlesional skin. PATIENTS/
METHODS: Skin samples were obtained from lesional and nonlesional facial skin of 60 Korean women with melasma. Immunohistochemistry and reverse transcriptase-polymerase chain reaction (RT-PCR) analysis was performed to determine the expression of SCF and c-kit in melasma.
RESULTS: The expression of SCF was significantly increased at the lesional dermis compared with nonlesional dermis. However, there was no significant difference in the expression of SCF in lesional and nonlesional epidermis. The expression of c-kit was significantly increased at lesional epidermis compared with nonlesional skin. RT-PCR of SCF and c-kit mRNAs demonstrated increased expression of both types of transcripts in the lesional skin compared with nonlesional skin.
CONCLUSIONS: These results suggest that the increased expression of SCF in the dermis and of c-kit in the epidermis play an important role in the mechanism of hyperpigmentation in melasma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16704639     DOI: 10.1111/j.1365-2133.2006.07179.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  20 in total

1.  What should be considered in treatment of melasma.

Authors:  Hee Young Kang; Jean-Paul Ortonne
Journal:  Ann Dermatol       Date:  2010-11-05       Impact factor: 1.444

2.  The dual toning technique for melasma treatment with the 1064 nm Nd: YAG laser: A preliminary study.

Authors:  Hy Kang; Jh Kim; Bc Goo
Journal:  Laser Ther       Date:  2011

3.  Sebocytes contribute to melasma onset.

Authors:  Enrica Flori; Arianna Mastrofrancesco; Sarah Mosca; Monica Ottaviani; Stefania Briganti; Giorgia Cardinali; Angela Filoni; Norma Cameli; Marco Zaccarini; Christos C Zouboulis; Mauro Picardo
Journal:  iScience       Date:  2022-02-04

Review 4.  Melasma in Men: A Review of Clinical, Etiological, and Management Issues.

Authors:  Rashmi Sarkar; Pallavi Ailawadi; Shilpa Garg
Journal:  J Clin Aesthet Dermatol       Date:  2018-02-01

Review 5.  Participation of keratinocyte- and fibroblast-derived factors in melanocyte homeostasis, the response to UV, and pigmentary disorders.

Authors:  Parth R Upadhyay; Tina Ho; Zalfa A Abdel-Malek
Journal:  Pigment Cell Melanoma Res       Date:  2021-05-24       Impact factor: 4.693

Review 6.  Heterogeneous Pathology of Melasma and Its Clinical Implications.

Authors:  Soon-Hyo Kwon; Young-Ji Hwang; Soo-Keun Lee; Kyoung-Chan Park
Journal:  Int J Mol Sci       Date:  2016-05-26       Impact factor: 5.923

Review 7.  Skin Pigmentation and Pigmentary Disorders: Focus on Epidermal/Dermal Cross-Talk.

Authors:  Emanuela Bastonini; Daniela Kovacs; Mauro Picardo
Journal:  Ann Dermatol       Date:  2016-05-25       Impact factor: 1.444

8.  Treatment of melasma in Caucasian patients using a novel 694-nm Q-switched ruby fractional laser.

Authors:  Said Hilton; Heike Heise; Bettina Alexandra Buhren; Holger Schrumpf; Edwin Bölke; Peter Arne Gerber
Journal:  Eur J Med Res       Date:  2013-11-14       Impact factor: 2.175

Review 9.  Inhibitors of intracellular signaling pathways that lead to stimulated epidermal pigmentation: perspective of anti-pigmenting agents.

Authors:  Genji Imokawa; Koichi Ishida
Journal:  Int J Mol Sci       Date:  2014-05-12       Impact factor: 5.923

10.  Skin Hyperpigmentation in Indian Population: Insights and Best Practice.

Authors:  Stephanie Nouveau; Divya Agrawal; Malavika Kohli; Francoise Bernerd; Namita Misra; Chitra Shivanand Nayak
Journal:  Indian J Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.